Testing effectiveness (Phase 2)WithdrawnNCT00048087What this trial is testingIressa/Docetaxel in Non-Small-Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Early research (Phase 1)Looking for participantsNCT07130916What this trial is testingAumolertinib in European Participants With Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Jiangsu Hansoh Pharmaceutical Co., Ltd. 20
Not applicableStudy completedNCT00003329What this trial is testingIdentification of Genes Associated With Cancer in Patients and Siblings Who Have CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+1 more Eastern Cooperative Oncology Group 4,000
Testing effectiveness (Phase 2)UnknownNCT01210053What this trial is testingSunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Third Military Medical University 30
Not applicableApproved For MarketingNCT04599712What this trial is testingPre-Approval Access With Amivantamab (JNJ-61186372) in Participants With Metastatic Non-Small Cell Lung CancerWho this might be right forMetastatic Non-Small Cell Lung Cancer Janssen Research & Development, LLC
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319What this trial is testingA Phase III Study of SKB264 for EGFR Mutant NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Testing effectiveness (Phase 2)Study completedNCT01116219What this trial is testingBevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).Who this might be right forLung Cancer Swiss Cancer Institute 149
Testing effectiveness (Phase 2)Active Not RecruitingNCT04919811What this trial is testingTaletrectinib Phase 2 Global Study in ROS1 Positive NSCLCWho this might be right forNon Small Cell Lung Cancer Nuvation Bio Inc. 217
Not applicableStudy completedNCT00277082What this trial is testingAerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the LungWho this might be right forCorpus UteriLung Cancer University of New Mexico 24
Not applicableStudy completedNCT00351962What this trial is testingPhase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung TumoursWho this might be right forLung NeoplasmsLung Cancer AHS Cancer Control Alberta 58
Large-scale testing (Phase 3)Looking for participantsNCT06899126What this trial is testingStudy of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Daiichi Sankyo 686
Early research (Phase 1)Looking for participantsNCT06266299What this trial is testingKK2269 in Adult Participants With Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more Kyowa Kirin Co., Ltd. 101
Not applicableStudy completedNCT00303914What this trial is testingStudy of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal CancerWho this might be right forBreast CancerCognitive/Functional EffectsColorectal Cancer+4 more Eastern Cooperative Oncology Group 2,310
Early research (Phase 1)Study completedNCT00052338What this trial is testingBortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerWho this might be right forMalignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more National Cancer Institute (NCI) 34
Not applicableStudy completedNCT00827333What this trial is testingPalliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung CancerWho this might be right forLung Cancer City of Hope Medical Center 372
Early research (Phase 1)UnknownNCT05430009What this trial is testingLiver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung CancerWho this might be right forLiver MetastasesNon-small Cell Lung Cancer VA Ann Arbor Healthcare System 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06311721What this trial is testingCompare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung CancerWho this might be right forAdvanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Amgen 315
Testing effectiveness (Phase 2)UnknownNCT05007938What this trial is testingBefotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung CancerWho this might be right forNon-Small Cell Lung Cancer Betta Pharmaceuticals Co., Ltd. 30
Testing effectiveness (Phase 2)Ended earlyNCT04971187What this trial is testingBintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung CancerWho this might be right forLocally Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more M.D. Anderson Cancer Center 3